ANXA1 and hydrops fetalis: Development of ANX-A1 mimetics that are resistant to degradation are particularly attractive for future translational studies, particularly for treating MI in the early hours after an ischemic event (while the injury is still evolving), alone or concurrent with standard care, to reduce progression to HF and death in affected patients.